Form 4: Organogenesis Holdings Inc.: Director Alan A. Ades Transfers Shares to Spouse for Estate Planning

Alan A. Ades, a director and 10% owner of Organogenesis Holdings Inc., transferred shares to his spouse, Josette Ades, as a gift for estate planning purposes on January 9, 2025.

Summary

• On January 9, 2025, Alan A. Ades transferred 6,401,945 shares of Class A Common Stock to his spouse, Josette Ades, as a gift.
• The transfer was for estate planning purposes and involved no consideration.
• Following the transaction, the Group, which includes Alan A. Ades, Josette Ades, and other related entities, collectively holds 51,085,402 shares.
• Alan A. Ades disclaims beneficial ownership of the securities held by his spouse.
• The Group is party to a Stockholders' Agreement that provides for nomination rights with respect to four directors of the Issuer.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment as it primarily reports a share transfer for estate planning purposes. There are no explicit positive or negative implications for the company's performance.

Positives

• The transfer is part of estate planning, which can be a proactive financial strategy.

Industry Context

This filing reflects insider activity related to estate planning, which is a common practice among high-net-worth individuals and corporate insiders. It doesn't necessarily indicate a change in the company's fundamentals or outlook.

Related Party Transactions

• The transfer of shares between Alan A. Ades and his spouse, Josette Ades, constitutes a related party transaction.

Stakeholder Impact

• The share transfer itself has minimal direct impact on stakeholders, as the total number of shares held by the Group remains unchanged.
• The estate planning activities of insiders are generally viewed as a personal matter and do not directly affect the company's operations or financial performance.

Key Dates